- Filed
- May 22, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 20, 2025 | 59.93M sh |
| Stock Repurchased | Q1 2025 · Apr 19, 2025 | $2M |
| Stock Repurchased restated | Q1 2025 · Apr 20, 2024 | $3M |
| Long Term Debt | Q1 2025 · Apr 19, 2025 | $1.49B |
| Long Term Debt | Q1 2025 · Dec 28, 2024 | $1.79B |
| Short Term Debt | Q1 2025 · Apr 19, 2025 | $299M |
| Short Term Debt | Q1 2025 · Dec 28, 2024 | $0 |
| Cash And Equivalents | Q1 2025 · Apr 19, 2025 | $1.67B |
| Cash And Equivalents | Q1 2025 · Dec 28, 2024 | $1.87B |
| Current Liabilities | Q1 2025 · Apr 19, 2025 | $4.79B |
| Current Liabilities | Q1 2025 · Dec 28, 2024 | $4.67B |
| Total Liabilities | Q1 2025 · Apr 19, 2025 | $8.42B |
| Total Liabilities | Q1 2025 · Dec 28, 2024 | $8.63B |
| Current Assets | Q1 2025 · Apr 19, 2025 | $6.08B |
| Current Assets | Q1 2025 · Dec 28, 2024 | $6.14B |
| Total Assets | Q1 2025 · Apr 19, 2025 | $10.62B |
| Total Assets | Q1 2025 · Dec 28, 2024 | $10.8B |
| Shares Diluted restated | Q1 2025 · Apr 20, 2024 | 59.8M sh |
| Dividends Paid restated | Q1 2025 · Apr 20, 2024 | $15M |
| Capex restated | Q1 2025 · Apr 20, 2024 | $46M |
| Operating Cash Flow restated | Q1 2025 · Apr 20, 2024 | $3M |
| Stockholders Equity restated | Q1 2025 · Apr 20, 2024 | $2.57B |
| Stockholders Equity restated | Q1 2025 · Dec 30, 2023 | $2.52B |
| Eps Diluted | Q1 2025 · Apr 20, 2024 | $0.67 |
| Eps Basic | Q1 2025 · Apr 20, 2024 | $0.67 |
| Sga Expense restated | Q1 2025 · Apr 20, 2024 | $1.15B |
| Net Income restated | Q1 2025 · Apr 20, 2024 | $40M |
| Operating Income restated | Q1 2025 · Apr 20, 2024 | $53M |
| Gross Profit restated | Q1 2025 · Apr 20, 2024 | $1.2B |
| Cost Of Revenue restated | Q1 2025 · Apr 20, 2024 | $1.57B |
| Revenue restated | Q1 2025 · Apr 20, 2024 | $2.77B |